Children's coping strategies for chemotherapy-induced nausea and vomiting

Cheryl Rodgers1, Robbie Norville, Olga Taylor

  • 1Department of Pediatrics, Baylor College of Medicine and Cancer and Hematology Service at Texas Children's Hospital, Houston, USA. ccrodger@txccc.org

Insights

Chemotherapy-induced nausea and vomiting (CINV) occurs throughout cancer treatment in children. Active coping strategies, like social support and distraction, are most effective for managing pediatric CINV.

Area of Science:

  • Pediatric Oncology
  • Symptom Management
  • Cancer Nursing

Background:

  • Chemotherapy-induced nausea and vomiting (CINV) is a common and distressing side effect for pediatric cancer patients.
  • Understanding the timing and patient-reported experiences of CINV is crucial for effective management.

Purpose of the Study:

  • To determine the frequency of anticipatory, acute, and delayed CINV in pediatric cancer patients.
  • To identify coping strategies utilized by children experiencing CINV.
  • To evaluate the effectiveness of different coping mechanisms.

Main Methods:

  • Prospective cohort study involving 40 children aged 7-12 years undergoing chemotherapy.
  • Utilized the Adapted Rhodes Index of Nausea and Vomiting for Pediatrics and Kidcope-Younger Version.
  • Assessed CINV occurrence and coping strategy use across different time points.

Main Results:

  • CINV was observed in anticipatory, acute, and delayed phases, with the highest incidence in the delayed phase.
  • Distraction and wishful thinking were most frequently used coping strategies.
  • Social support and distraction were identified as the most effective coping strategies.

Conclusions:

  • Chemotherapy-induced nausea and vomiting (CINV) is a persistent issue throughout pediatric cancer treatment.
  • Active coping strategies, including social support and distraction, demonstrate greater efficacy in managing CINV.
  • Nurses play a vital role in educating and empowering children with active coping mechanisms for CINV.
Abstract

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
Coping Strategies: Problem Focused01:27

Coping Strategies: Problem Focused

Coping strategies are methods people use to manage, tolerate, or reduce the effects of stressors. These strategies involve both behavioral and psychological actions to handle stressful situations. One common approach is problem-focused coping, which aims to change or eliminate the source of stress rather than merely addressing its consequences. This method involves taking direct action to resolve the issue causing stress.
For example, consider a student who struggles to understand their...